Aredia Judge Tosses More Failure-To-Warn Claims
Novartis Pharmaceuticals Corp. has prevailed again in its ongoing bid to get failure-to-warn claims tossed from cases in the multidistrict litigation over its bone cancer drugs Aredia and Zometa....To view the full article, register now.
Already a subscriber? Click here to view full article